International Journal of Pediatrics

Volume 2013 (2013), Article ID 953103, 6 pages

http://dx.doi.org/10.1155/2013/953103

Research Article

Evaluation of Attention-Deficit Hyperactivity Disorder Risk Factors

Javad Golmirzaei,¹ Shole Namazi,¹ Shahrokh Amiri,2,3 Shahram Zare,⁴ Najme Rastikerdar,¹ Ali Akbar Hesam,⁵ Zahra Rahami,⁶ Fatemeh Ghasemian,⁶ Seyyed Shojaeddin Namazi,⁷ Abbas Paknahad,⁷ Forugh Mahmudi,⁸ Hamidreza Mahboobi,⁶ Tahereh Khorgoei,⁶ Bahareh Niknejad,⁶ Fatemeh Dehghani,⁶ and Shima Asadi⁶

¹Research Center for Behavioral and Neurosciences, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

²Clinical Psychiatry Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

³Department of Psychiatry, Razi Hospital, Elgoli Road, Tabriz, East Azerbaijan, Iran

⁴Hormozgan University of Medical Sciences, Bandar Abbas, Iran

⁵Department of Epidemiology, Islamic Azad University, Bandar Abbas, Iran

⁶Student Research Committee, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

⁷Tropical and Infectious Disease Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

⁸Fertility and Infertility Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

Received 1 August 2013; Accepted 10 September 2013

Academic Editor: Namık Yaşar Özbek

Copyright © 2013 Javad Golmirzaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Attention-deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders among children. The aim of this study was to evaluate risk factors for ADHD in children. Method. In this case-control study, 404 children between 4 and 11 years old were selected by cluster sampling method from preschool children (208 patients as cases and 196 controls). All the participants were interviewed by a child and adolescent psychiatrist to survey risk factors of ADHD. Results. Among cases, 59.3% of children were boys and 38.4% were girls, which is different to that in control group with 40.7% boys and 61.6% girls. The chi-square showed statistically significance ( value < 0.0001). The other significant factors by chi-square were fathers' somatic or psychiatric disease ( value < 0.0001), history of trauma and accident during pregnancy ( value = 0.039), abortion proceeds ( value < 0.0001), unintended pregnancy ( value < 0.0001), and history of head trauma ( value < 0.0001). Conclusions. Findings of our study suggest that maternal and paternal adverse events were associated with ADHD symptoms, but breast feeding is a protective factor.

1. Introduction

Attention-deficit hyperactivity disorder (ADHD) is one of the most common behavioral and neurodevelopmental disorders which is characterized by hyperactivity, impulsivity, and inattention in children and adolescents [1]. Prevalence of ADHD among school-aged children in different studies varies between 5 and 12% [1, 2], whereas the prevalence of this disorder declines with increasing age [3]. It is estimated that this disorder persists into adulthood in 50% of afflicted children [4]. Children with ADHD are at increased risk of antisocial behavior, learning disabilities, drug abuse, impaired academic performance, impaired executive functions, communication disorders, speech problems, and comorbid psychiatric disorders [5, 6]. Although, the pathogenesis of ADHD is still unknown, primary and secondary factors are estimated to be implicated in ADHD pathogenesis. Primary roles are shaped in the cerebral cortex by catecholamine metabolism. Also, etiology of ADHD is attributed to genetic factors in about 80% [7]. The secondary roles are created by various environmental factors [8, 9]. Some of these factors, which are associated with ADHD, are pregnancy and birth related risk factors which are classified into three groups including prenatal, perinatal, and postnatal risk factors. Regarding prenatal risk factors, a large number of studies have shown that maternal exposure to alcohol, tobacco, and cocaine during pregnancy increases the risk of ADHD. On the other hand, some studies showed that prenatal viral infections are associated with increased risk of ADHD [10, 11]. Various studies have demonstrated that preeclampsia, maternal anemia, lower serum level of iron and iodine, and trauma to abdomen during pregnancy are associated with increased risk of ADHD development [10, 12]. Regarding perinatal risk factors, a number of risk factors such as prematurity, low birth weight, and breech delivery are estimated to be associated with increased risk of ADHD [13]. Postnatal risk factors include postnatal viral infections such as measles, varicella, and rubella increasing the risk of developing ADHD [13]. Additionally, several other factors such as breast-feeding, head injury in early childhood and adolescence, encephalitis, convulsion and endocrine disorder are estimated to be risk factors for development of ADHD [13, 14].

Although the association of breastfeeding and ADHD is not established, some studies have shown that ADHD is more common in children with lower rates of breast feeding [15]. The role of other factors such as unintended pregnancy, X-ray exposure, and previous abortion is not established [16]. In addition to the mentioned factors, several sociodemographic factors such as maternal education, family income, male gender, and maternal age at pregnancy are known to be predictive factors for developing ADHD [12, 13]. Some studies have shown that maternal emotional stress during pregnancy is related to increased risk of psychobehavioral disorders such as ADHD [17]. Prematurity, maternal alcohol consumption, and smoking are associated with ADHD symptoms [15, 16]. However, data on other risk factors are less well established. With respect to destructive complication of ADHD and its negative effects on psychosocial behavior of children with this disorder, we aimed to determine the ADHD risk factors among the school-aged children in Bandar Abbas.

2. Method

This case-control study was carried out among 404 children aged 4–11 years that were selected by cluster sampling in southern Iran in 2012. This study was approved by the ethics committee of Hormozgan University of Medical Sciences (HUMS). Informed consent was obtained from their parents or legal guardians. In this study, 935 preschool children were selected using cluster sampling and all of them were screened by Conners’ parents and teachers rating scales. Out of them, 271 children were positive for ADHD according to Conners’ questionnaire and those who were positive for ADHD (271) were interviewed by a child and adolescent psychiatrist and 208 children who met DSM-IV criteria for ADHD were enrolled in this study.

This questionnaire had 28 items with answers based on Likert scales. The total possible score was 84 and children with a parent or teacher questionnaire total score above 70 were considered as positive and referred to Ebne-Sina Hospital, the only behavioral and neuroscience center in Hormozgan Province.

All of the selected children were interviewed by a specialist in child and adolescent psychiatry. The cases were selected among patients who met the diagnostic criteria of DMS-IV for ADHD and controls were chosen among healthy children. The participants in each group were matched for age. Their parents were asked to answer the questionnaire including maternal and pregnancy related risk factors for ADHD such as the mother age at pregnancy, thyroid disease, the length of pregnancy, exposure to X-ray, infectious disease, eclampsia, abnormal uterine bleeding, abdominal trauma, medication intake, alcohol and tobacco consumption during pregnancy, and previous abortion, as well as neonatal and infantile related risk factors such as unwanted pregnancy, type of delivery, hyperbilirubinemia, phototherapy, blood exchange, low birth weight (less than 2.5 kg), feeding (breastfeeding or formula feeding), childhood asthma, dysentery, epilepsy, head trauma, and thyroid disease. In addition, parents’ educational level, economic level, and presence of psychiatric disease in children and their parents were documented.

Data was analyzed using statistical procedures for social sciences (SPSS; version 19) by descriptive analysis such as mean, standard deviation and percentile frequency. Differences between case and control groups were analyzed by chi-square test. A value of was considered significant.

3. Results

A total of 404 children met the enrollment criteria, including 208 children as case group and 196 as controls. The mean age of participants in case and control groups was and years, respectively. There was no significant difference between both groups ().

Among ADHD children, 150 (59.3%) were boys and 58 (38.4%) were girls. Among controls, 103 (40.7%) and 93 (61.6%) were boys and girls, respectively. Chi-square demonstrated that ADHD was significantly higher among boys than girls (, OR: 3, 95% CI: (1.34–6.635)).

The results showed that a history of trauma to abdomen during pregnancy was significantly higher among mothers who had children with ADHD. Maternal, pregnancy, neonatal risk factors for ADHD, and maternal and paternal history of psychiatric disorders are listed in Tables 1 and 2.

Table 1: Maternal, pregnancy, and neonatal risk factors for ADHD among case and control subjects.

Proposed risk factor
Group
Number (%)
OR (95% CI)
value

Trauma to abdomen in pregnancy
ADHD
7 (3.4%)
4 (0.000–1000)
0.039

Control
1 (0.5%)

X-ray exposure
ADHD
2 (1%)

NS*

Control
1 (0.05%)

Vaginal bleeding
ADHD
8 (3.9%)

NS

Control
11 (5.6%)

Infectious disease during pregnancy
ADHD
7 (3.4%)

NS

Control
5 (2.5%)

Cigarette and alcohol consumption
ADHD
25 (12.1%)

<0.0001

Control
4 (2%)

Preeclampsia
ADHD
20 (9.7%)

0.009

Control
6 (3%)

Dysentery
ADHD
8 (3.9%)

NS

Control
11 (5.6%)

Cesarean section
ADHD
107 (51.7%)

0.019

Control
81 (40.9%)

Unwanted pregnancy
ADHD
29 (14%)
4.2 (0.000–1000)
<0.0001

Control
5 (2.5%)

Previous abortion
ADHD
36 (17.4%)
24 (0.594–977.082)
<0.0001

Control
11 (5.6%)

Somatic disease at pregnancy
ADHD
14 (6.8%)

0.007

Control
3 (1.5%)

Psychiatric disease at pregnancy
ADHD
17 (8.2%)

0.004

Control
4 (2%)

Formula feeding
ADHD
75 (36.6%)

<0.0001

Control
39 (24.9%)

NS: not significant.

Table 2: Chi-square test for parental psychiatric disorders and their familial relation among case and control groups.

Group
Number (%)
OR (95% CI)
value

Related parents
ADHD
51 (24.6%)

0.012

Control
70 (35.4%)

Maternal psychiatric disorder
ADHD
46 (22.2%)

<0.0001

Control
11 (5.6%)

Paternal psychiatric disorder
ADHD
52 (25.2%)
8.7 (0.71–106.3)
<0.0001

Control
19 (9.6%)

As shown in Table 3, among neonatal and childhood risk factors, childhood head trauma and epilepsy were associated with AHDH.

Table 3: Neonatal and childhood related risk factors for ADHD among case and control groups.

Group
Number (%)
OR (95% CI)
value

Asthma
ADHD
20 (9.7%)

NS

Control
17 (8.6%)

Epilepsy
ADHD
13 (6.3%)

0.001

Control
1 (0.5%)

Dysentery
ADHD
5 (2.4%)

NS

Control
3 (1.5%)

Childhood head trauma
ADHD
44 (21.3%)
4.4 (0.000–1000)
<0.0001

Control
2 (1%)

Thyroid disease
ADHD
2 (1%)

NS

Control
0 (0%)

Hyperbilirubinemia
ADHD
101 (48.8%)

NS

Control
81 (40.9%)

Low birth weight
ADHD
16 (7.8%)

NS

Control
24 (12.1%)

4. Discussion

This cross-sectional case-control study was performed to determine the risk factors of ADHD.

Symptoms of ADHD almost present in early childhood after 3 years of age and before 7. It may be continued to adulthood and affect the interpersonal impairments, academic performance, and work and family problems. Untimely diagnosis and treatment of this disorder can lead to cognitive and behavioral impairments. In recent years, numerous investigations have been done to identify the etiology of this disorder and the related factors.

In the current study, ADHD was diagnosed three times in male children compared to females. This finding was consistent with the results of other studies conducted by Kim et al. [18] and Cantwell [19].

There are converging lines of evidence regarding the role of genetic factors in developing ADHD [20]. Our findings showed that parental psychiatric disorder was significantly associated with ADHD in children. This finding was consistent with previous studies [21, 22]. Moreover, our results showed that ADHD was more frequent among those children of nonrelated parents compared to related parents. This could be due to the increased chance of distribution of genetic role and mutation when children are born to nonrelated parents.

Controversial findings have been reported about the role of thyroid hormones in ADHD [23, 24], while some lines of evidence revealed that ADHD is more frequent in patients with a generalized resistance to thyroid hormones compared to normal population [25]. Our finding showed that thyroid disease was not significantly higher among patients with ADHD compared to control children. Screening of ADHD children for thyroid disease is not recommended unless the symptoms of hypo/hyperthyroidism are observed [26].

Alcohol exposure during pregnancy is related to increased risk of neurodevelopmental and conductive disorders. This association is well documented [27]. Our results showed that alcohol and tobacco exposure during pregnancy would increase the risk of ADHD. These findings are consistent with the results of other authors [28–30].

There are few studies regarding the association of preeclampsia in pregnancy and ADHD in their children. Some studies have shown that pregnancy complications are associated with increased risk of offspring ADHD [10, 31]. However, Amiri reported that a history of preeclampsia and infections during pregnancy were not significantly higher among mothers of children with ADHD [12]. Our findings revealed that trauma to abdomen, previous abortion, unwanted pregnancy, preeclampsia, and cesarean section were significantly higher among patients with ADHD compared to control subjects. But X-ray exposure, infectious disease, dysentery, and vaginal bleeding at pregnancy were not associated with increased risk of ADHD.

Various studies demonstrated that low birth weight among ADHD children was significantly higher than normal children [28, 32]. But in this study, low birth weight was not significantly higher in children with ADHD.

The results of our study demonstrated that prevalence of ADHD among formula-fed patients was significantly higher than breast-fed children. This finding is consistent with the results of other studies. Some lines of evidence demonstrated that fatty acid compositions of human breast milk such as docosahexaenoic acid and arachidonic acid have an important role in brain development [33, 34]. The results of our study may be due to the role of fatty acids in brain growth during neonatal and infancy stages [35]. In addition, a review by Mazza and colleagues reported that fatty acids are associated with other psychotic disorders [36].

Our results showed that epilepsy and trauma to head were significantly higher among ADHD children than control group. On the other hand, the difference of the frequency of childhood asthma, dysentery, and thyroid disease was not significant between both groups. Our result was consistent with a study conducted by Gerring and colleagues that reported that ADHD was more frequent among patients who presented with moderate and severe head injuries [37]. Furthermore, another finding that was consistent with our results was reported by Dunn and colleagues; they demonstrated that children with epilepsy are at increased risk of ADHD in the future [38]. It is estimated that about 20% of children with epilepsy may develop ADHD [39]. Recently, various studies examine the effect of methylphenidate on seizure frequency among patients with concomitant ADHD and epilepsy. These evidences showed that methylphenidate is an effective and safe medication for patients with both epilepsy and ADHD [39, 40].

Although in this study we tried to eliminate the overestimation or underestimation of ADHD by parents of children, whoever they are, a limitation in our study could be the probable recall bias by the parents.

In conclusion, our study demonstrated that parental psychiatric disorders, previous abortion, unwanted pregnancy, cesarean delivery, maternal alcohol and tobacco exposure during pregnancy, epilepsy, and head trauma were significantly more among ADHD children than control group. Accordingly, avoiding alcohol, tobacco, and unnecessary X-ray during pregnancy and elective cesarean delivery are recommended as well as feeding by breast milk instead of formula. However, it must be taken into consideration that alcohol and tobacco exposure, previous abortion, and unwanted pregnancy may be results of maternal and paternal ADHD.

Conflict of Interests

The authors declare that they have no conflict of interests.

References

K. M. Linnet, S. Dalsgaard, G. Obel et al., “Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence,” American Journal of Psychiatry, vol. 160, no. 6, pp. 1028–1040, 2003.

N. Grizenko, Y. R. Shayan, A. Polotskaia, M. Ter-Stepanian, and R. Joober, “Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD,” Journal of Psychiatry and Neuroscience, vol. 33, no. 1, pp. 10–16, 2008.

S. V. Faraone, J. Sergeant, C. Gillberg, and J. Biederman, “The worldwide prevalence of ADHD: is it an American condition?” World Psychiatry, vol. 2, no. 2, pp. 104–113, 2003.

J. Biederman and S. V. Faraone, “Attention-deficit hyperactivity disorder,” The Lancet, vol. 366, no. 9481, pp. 237–248, 2005.

S. V. Faraone, J. Biederman, D. Mennin, R. Russell, and M. T. Tsuang, “Familial subtypes of attention deficit hyperactivity disorder: a 4-year follow-up study of children from Antisocial-ADHD families,” Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 39, no. 7, pp. 1045–1053, 1998.

S. Amiri, A. Fakhari, J. Golmirzaei, A. Mohammadpoorasl, and S. Abdi, “Tourette's syndrome, chronic tics, and comorbid attention deficit/hyperactivity disorder in elementary students,” Archives of Iranian Medicine, vol. 15, no. 2, pp. 76–78, 2012.

J. Biederman and S. V. Faraone, “Current concepts on the neurobiology of attention-deficit/hyperactivity disorder,” Journal of Attention Disorders, vol. 6, no. 1, pp. S-7–S-16, 2002.

A. O. Action, “Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder,” Journal of the American Academy of Child & Adolescent Psychiatry, vol. 46, no. 7, pp. 894–921, 2007.

J. G. Millichap, “Etiologic classification of attention-deficit/hyperactivity disorder,” Pediatrics, vol. 121, no. 2, pp. e358–e365, 2008.

J. R. Mann and S. McDermott, “Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children?” Journal of Attention Disorders, vol. 15, no. 8, pp. 667–673, 2011.

C. Arpino, M. Marzio, L. D'Argenzio, B. Longo, and P. Curatolo, “Exanthematic diseases during pregnancy and attention-deficit/ hyperactivity disorder (ADHD),” European Journal of Paediatric Neurology, vol. 9, no. 5, pp. 363–365, 2005.

S. Amiri, A. Malek, M. Sadegfard, and S. Abdi, “Pregnancy-related maternal risk factors of attention-deficit hyperactivity disorder: a Case-Control Study,” ISRN Pediatrics, vol. 2012, Article ID 458064, 2012.

J. G. Millichap, “Etiologic classification of attention-deficit/hyperactivity disorder,” Pediatrics, vol. 121, no. 2, pp. e358–e365, 2008.

J. Osorio, “Thyroid function: autoimmunity in pregnancy and ADHD,” Nature Reviews Endocrinology, vol. 8, no. 3, article 129, 2012.

J. Stolzer, “ADHD in America: a bioecological analysis,” Ethical Human Psychology and Psychiatry, vol. 7, no. 1, pp. 65–75, 2005.

S. Amiri, A. Malek, M. Sadegfard, and S. Abdi, “Pregnancy-related maternal risk factors of attention-deficit hyperactivity disorder: a Case-Control Study,” ISRN Pediatrics, vol. 2012, Article ID 458064, 5 pages, 2012.

A. Ronald, C. E. Pennell, and A. J. Whitehouse, “Prenatal maternal stress associated with ADHD and autistic traits in early childhood,” Frontiers in Psychology, vol. 1, article 223, 2010.

H.-W. Kim, S.-C. Cho, B.-N. Kim, J.-W. Kim, M.-S. Shin, and Y. Kim, “Perinatal and familial risk factors are associated with full syndrome and subthreshold attention-deficit hyperactivity disorder in a Korean community sample,” Psychiatry Investigation, vol. 6, no. 4, pp. 278–285, 2009.

D. P. Cantwell, “Attention deficit disorder: a review of the past 10 years,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 35, no. 8, pp. 978–987, 1996.

T. S. Nadder, J. L. Silberg, L. J. Eaves, H. H. Maes, and J. M. Meyer, “Genetic effects on ADHD symptomatology in 7- to 13-year-old twins: results from a telephone survey,” Behavior Genetics, vol. 28, no. 2, pp. 83–99, 1998.

M. Stormont-Spurgin and S. S. Zentall, “Child-rearing practices associated with aggression in youth with and without ADHD: an Exploratory Study,” International Journal of Disability, Development and Education, vol. 43, no. 2, pp. 135–146, 1996.

A. Thapar, T. Fowler, F. Rice et al., “Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring,” American Journal of Psychiatry, vol. 160, no. 11, pp. 1985–1989, 2003.

M. A. Stein and R. E. Weiss, “Thyroid function tests and neurocognitive functioning in children referred for attention deficit/hyperactivity disorder,” Psychoneuroendocrinology, vol. 28, no. 3, pp. 304–316, 2003.

A. A. Kraut, I. Langner, C. Lindemann, T. Banaschewski, U. Petermann, F. Petermann, et al., “Comorbidities in ADHD children treated with methylphenidate: a Database Study,” BMC Psychiatry, vol. 13, no. 1, article 11, 2013.

R. E. Weiss, M. A. Stein, B. Trommer, and S. Refetoff, “Attention-deficit hyperactivity disorder and thyroid function,” Journal of Pediatrics, vol. 123, no. 4, pp. 539–545, 1993.

J. Valentine, E. Rossi, P. O'Leary, T. S. Parry, J. J. Kurinczuk, and P. Sly, “Thyroid function in a population of children with attention deficit hyperactivity disorder,” Journal of Paediatrics and Child Health, vol. 33, no. 2, pp. 117–120, 1997.

L. Vaurio, E. P. Riley, and S. N. Mattson, “Differences in executive functioning in children with heavy prenatal alcohol exposure or attention-deficit/hyperactivity disorder,” Journal of the International Neuropsychological Society, vol. 14, no. 1, pp. 119–129, 2008.

T. D. Banerjee, F. Middleton, and S. V. Faraone, “Environmental risk factors for attention-deficit hyperactivity disorder,” Acta Paediatrica, International Journal of Paediatrics, vol. 96, no. 9, pp. 1269–1274, 2007.

T. M. M. Button, B. Maughan, and P. McGuffin, “The relationship of maternal smoking to psychological problems in the offspring,” Early Human Development, vol. 83, no. 11, pp. 727–732, 2007.

C. Obel, K. M. Linnet, T. B. Henriksen et al., “Smoking during pregnancy and hyperactivity-inattention in the offspring—comparing results from three Nordic cohorts,” International Journal of Epidemiology, vol. 38, no. 3, pp. 698–705, 2009.

A. Halmøy, K. Klungsøyr, R. Skjærven, and J. Haavik, “Pre- and perinatal risk factors in adults with attention-deficit/hyperactivity disorder,” Biological Psychiatry, vol. 71, no. 5, pp. 474–481, 2012.

C. M. Hultman, A. Torrång, C. Tuvblad, S. Cnattingius, J.-O. Larsson, and P. Lichtenstein, “Birth weight and attention-deficit/hyperactivity symptoms in childhood and early adolescence: a prospective Swedish twin study,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 46, no. 3, pp. 370–377, 2007.

M. Mulhern, A. Yeates, E. McSorley, J. Wallace, G. Myers, P. Davidson, et al., “Maternal long chain polyunsaturated fatty acid status is associated with child growth,” Proceedings of the Nutrition Society, vol. 72, no. OCE2, article E100, 2013.

M. Makrides, L. G. Smithers, and R. A. Gibson, “Role of long-chain polyunsaturated fatty acids in neurodevelopment and growth,” Nestle Nutrition Workshop Series, vol. 65, pp. 123–136, 2010.

M. Singh, “Essential fatty acids, DHA human brain,” Indian Journal of Pediatrics, vol. 72, no. 3, pp. 239–242, 2005.

M. Mazza, M. Pomponi, L. Janiri, P. Bria, and S. Mazza, “Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 31, no. 1, pp. 12–26, 2007.

J. P. Gerring, K. D. Brady, A. Chen et al., “Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 37, no. 6, pp. 647–654, 1998.

D. W. Dunn, J. K. Austin, J. Harezlak, and W. T. Ambrosius, “ADHD and epilepsy in childhood,” Developmental Medicine and Child Neurology, vol. 45, no. 1, pp. 50–54, 2003.

M. Tan and R. Appleton, “Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy,” Archives of Disease in Childhood, vol. 90, no. 1, pp. 57–59, 2005.

K. Gucuyener, A. K. Erdemoglu, S. Senol, A. Serdaroglu, S. Soysal, and I. Kockar, “Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities,” Journal of Child Neurology, vol. 18, no. 2, pp. 109–112, 2003.